Jiangsu Hengrui Pharmaceuticals Co., Ltd. competitive analysis

Explore Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 29, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 28, 2026Fused Imidazole Derivative, Preparation Method Therefor, And Medical Use Thereof1

Latest PTAB cases involving Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Discover the latest PTAB cases involving Jiangsu Hengrui Pharmaceuticals Co., Ltd., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Jiangsu Hengrui Pharmaceuticals Co., Ltd. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JIANGSU HENGRUI PHARMACEUTICALS - 1 - -
JAMES POOLE207 - - -